![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
Adimab, Innovent collaborate on discovery, commercialization of antibody-based therapeutic
Adimab and Innovent have collaborated to discover, develop and commercialise an antibody-based therapeutic, using Adimab...
Supernus to launch Trokendi extended release formulation to treat epilepsy
Specialty pharmaceutical company Supernus Pharmaceuticals is set to launch once-daily extended release formulation of topiramate,...
Takeda announces availability of type 2 diabetes drugs in US
Takeda Pharmaceutical Company has announced the availability of NESINA (alogliptin) and fixed-dose combinations KAZANO (alogliptin...
Amedra re-launches Adrenaclick to treat anaphylaxis
Amedra Pharmaceuticals has re-launched a single-dose epinephrine auto-injector Adrenaclick for people with increased risk of...
Eisai to market and distribute Belviq weight management therapy in US
Eisai has announced the availability of Belviq (lorcaserin HCl) CIV tablets in the US, which...
Johnson & Johnson opens California Innovation Center
Johnson & Johnson (J&J) Innovation has opened the new California Innovation Center to build early...
Second Genome signs microbiome drug discovery deal with Janssen
Second Genome has signed a microbiome drug discovery deal with Janssen Biotech to advance novel...
USPTO issues notice of allowance for GW Pharmaceuticals Sativex formulation spray device
The USPTO has issued a notice of allowance for GW Pharmaceuticals' patent application regarding...
Nuvo Research announces launch of Pliaglis in Europe
Specialty pharmaceutical company Nuvo Research has announced the launch of Pliaglis (lidocaine and tetracaine)...
UK, India sign deal to support R&D, innovation projects
The Technology Strategy Board (TSB) in the UK and the Indian government's Department of...